Dear Colleagues,

Danio rerio, a small teleost commonly known as zebrafish, has emerged as a powerful model organism for studying a wide variety of human diseases over the last few decades due to its small size, high fecundity, and genetic and genomic similarity to humans. Especially phenotype-based zebrafish testing, the so-called “zebrafish screening”, has been actively utilized to identify drug target molecules and therapeutic compounds in combination with various high-throughput technological innovations, such as high-content imager, large-scale behavior analysis, robotics, and bioinformatics.

This Center intended to perform and construct zebrafish screening from broader perspectives, ranging from the creation of human diseases models, and technologies harnessing these as a model organism.

Sincerely yours,
Director. Yasuhito Shimada, M.D., Ph.D.
Dept. Integrative Pharmacology, Mie University Graduate School of Medicine, Japan.